Wuhan General Group

Wuhan General Group

M2Bio Sciences, a company that develops innovative healthcare solutions through cannabis and mushroom-based sciences, with focus on psilocybin and cannabinoids, targeting drug discovery and treatment sales in anxiety, depression, ADHD.

HQ location
Reno, United States
Website
m2bio.ai
Launch date
Employees
11-50 people
Market cap
$5.5k
Enterprise value
$6k
Share price
$0.00 WUHN
Recent deals
https://twitter.com/m2biohttps://www.linkedin.com/company/m2bio
    • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round

$450k

Post IPO Equity
Total Funding000k
ThreeD Capital
ThreeD Capital

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Wuhan General Group

Edit
JDAX
JDAX
ACQUISITION by Wuhan General Group Jun 2023